摘要
目的观察0.01%阿托品滴眼液治疗青少年近视的疗效及副作用。方法选取我市2014—2015年诊断为近视眼的7~13岁患者105例,随机分为1%阿托品组,0.01%阿托品组,验光配镜组,定期复查患者视力,眼压,眼轴及屈光度,对患者随访1年,比较治疗前后的视力,眼轴及屈光度情况。结果 1%阿托品组和0.01%阿托品组均与验光配镜组治疗前后屈光度及眼轴之间的差异有统计学意义(P<0.05),但1%阿托品组导致患者视近及畏光症状明显。结论 0.01%阿托品滴眼液治疗青少年近视临床效果好,能有效延缓患者的屈光度及眼轴的增长,且不良反应的发生率极低,长期使用较为安全。
Objective To observe the effcacy and side effects of atropine 0.01% eye drops in the treatment of juvenile myopia. Methods 105 cases of 7~13 years old patients with myopia diagnosed in our city from 2014 to 2015 were selected, they were randomly divided into 1% atropine groups, 0.01% atropine group, optometry group, the visual acuity, intraocular pressure, axial length and diopter of the patients were reviewed regularly. the patients were followed up for 1 years, the visual acuity before and after treatment was compared, eye axis and diopter. Results 1% atropine group and 0.01% atropine group and the difference between the diopter and axial length before and after optometry treatment group was statistically signifcant （P 〈 0.05）, but the 1% atropine group in patients with obvious symptoms of photophobia and near vision. Conclusion 0.01% atropine eye drops in the treatment of juvenile myopia clinical effect is good, can effectively delay the patient＇s diopter and axial growth, and the incidence of adverse reactions is very low, long term use is safer.
出处
《中国卫生标准管理》
2017年第22期79-80,共2页
China Health Standard Management
